(vin-BLAS-teen SUL-fayt)
Vinblastine sulfate is a type of chemotherapy called a vinca alkaloid. Vinca alkaloids interfere with microtubules (cellular structures that help move chromosomes during mitosis). They block cell growth by stopping mitosis (cell division).
FDA label information for this drug is available at DailyMed.
Use in Cancer
Vinblastine sulfate is approved as palliative treatment for:
- Breast cancer that has not gotten better with other treatment. It is used in adults.
- Choriocarcinoma (a type of gestational trophoblastic disease) that has not gotten better with other chemotherapy. It is used in adults.
- Hodgkin lymphoma. It is used in adults and children with advanced disease.
- Kaposi sarcoma. It is used in adults.
- Mycosis fungoides (a type of cutaneous T-cell lymphoma). It is used in adults.
- Non-Hodgkin lymphoma (NHL) in adults.
- Testicular germ cell tumors. It is used in adults and children with advanced disease.
More About Vinblastine Sulfate
Definition from the NCI Drug Dictionary – Detailed scientific definition and other names for this drug.
More About Vinblastine Sulfate – A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Vinblastine Sulfate – Check for trials from NCI’s list of cancer clinical trials now accepting patients.
